Immune Checkpoint Inhibitor에 의한 다발신경병의 Rituximab 치료
Rituximab Treatment for Polyneuropathy Induced by an Immune Checkpoint Inhibitor
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Immune checkpoint inhibitor is associated with variety of immune-related adverse events. We present a case of polyneuropathy induced by immune checkpoint inhibitor, which was refractory to steroid and immunoglobulin. While high-dose steroid and immunoglobulin were not effective, we tried rituximab which is effective in other immune-mediated polyneuropathy. After rituximab treatment, patient’s clinical symptom and nerve conduction study finding was markedly improved. We suggest rituximab might be effective in polyneuropathy induced by immune checkpoint inhibitor
Abstract
Immune checkpoint inhibitor is associated with variety of immune-related adverse events. We present a case of polyneuropathy induced by immune checkpoint inhibitor, which was refractory to steroid and immunoglobulin. While high-dose steroid and immunoglobulin were not effective, we tried rituximab which is effective in other immune-mediated polyneuropathy. After rituximab treatment, patient’s clinical symptom and nerve conduction study finding was markedly improved. We suggest rituximab might be effective in polyneuropathy induced by immune checkpoint inhibitor
참고문헌 (10)
- Topalian SL, "Safety, activity, and immune correlates of anti-PD-1 antibody in cancer", N Engl J Med, 366, pp.2443~2454 (2012)
- Michot JM, "Immune-related adverse events with immune checkpoint blockade : a comprehensive review", Eur J Cancer, 54, pp.139~148 (2016)
- Bot I, "Neurological immune-related adverse events of ipilimumab", Pract Neurol, 13, pp.278~280 (2013)
- Motamed-Gorji N, "Biological drugs in Guillain-Barré syndrome : an update", Curr Neuropharmacol, 15, pp.938~950 (2017)
- Sakai K, "A case of nivolumab-induced severe mononeuropathy multiplex and rhabdomyolysis", Case Rep Med, 2017, pp.1093858~ (2017)
- Gu Y, "Immune mediated neuropathy following checkpoint immunotherapy", J Clin Neurosci, 45, pp.14~17 (2017)
- Fukumoto Y, "Acute demyelinating polyneuropathy induced by nivolumab", J Neurol Neurosurg Psychiatry, 89, pp.435~437 (2018)
- Weber JS, "Management of immune-related adverse events and kinetics of response with ipilimumab", J Clin Oncol, 30, pp.2691~2697 (2012)
- Williams TJ, "Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer", JAMA Neurol, 73, pp.928~933 (2016)
- Ito M, "Rituximab for nivolumab plus ipilimumab-induced encephalitis in a small-cell lung cancer patient", Ann Oncol, 28, pp.2318~2319 (2017)